| 國立成功大學 |
2022 |
A Fast, Interactive, Location-Based Food Recommendation Application
|
Chiu, S.-M.;Chen, Y.-C.;Liou, Y.-S.;Lee, C.;Ying, J.-C.;Loh, C.-H.;Lin, J.-W. |
| 臺大學術典藏 |
2021-12-22T03:54:38Z |
The Impact of Lesion Length on Angiographic Restenosis after Vertebral Artery Origin Stenting
|
Lin Y.H.; Liu Y.C.; Tseng W.Y.I.; Juang J.M.; Hung C.S.; Lin J.W.; JIANN-SHING JENG; Yip P.K.; Kao H.L. |
| 臺大學術典藏 |
2021-12-02T02:26:11Z |
Association of amino-terminal pro-brain natriuretic peptide with metabolic syndrome
|
WEN-YI LI; Chiu F.-C.; Chien Y.-F.; Lin J.-W.; Hwang J.-J. |
| 臺大學術典藏 |
2021-12-02T02:26:11Z |
Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting
|
Huang T.-M.; Wu V.-C.; Young G.-H.; Lin Y.-F.; Shiao C.-C.; Wu P.-C.; WEN-YI LI; Yu H.-Y.; Hu F.-C.; Lin J.-W.; Chen Y.-S.; Lin Y.-H.; Wang S.-S.; Hsu R.-B.; Chang F.-C.; Chou N.-K.; Chu T.-S.; Yeh Y.-C.; Tsai P.-R.; Huang J.-W.; Lin S.-L.; Chen Y.-M.; Ko W.-J.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:30Z |
Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting
|
Huang T.-M.; VIN-CENT WU; Young G.-H.; Lin Y.-F.; Shiao C.-C.; Wu P.-C.; Li W.-Y.; Yu H.-Y.; Hu F.-C.; Lin J.-W.; Chen Y.-S.; Lin Y.-H.; Wang S.-S.; Hsu R.-B.; Chang F.-C.; Chou N.-K.; Chu T.-S.; Yeh Y.-C.; Tsai P.-R.; Huang J.-W.; Lin S.-L.; Chen Y.-M.; Ko W.-J.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:26Z |
Kidney impairment in primary aldosteronism
|
VIN-CENT WU; Yang S.-Y.; Lin J.-W.; Cheng B.-W.; Kuo C.-C.; Tsai C.-T.; Chu T.-S.; Huang K.-H.; Wang S.-M.; Lin Y.-H.; Chiang C.-K.; Chang H.-W.; Lin C.-Y.; Lin L.-Y.; Chiu J.-S.; Hu F.-C.; Chueh S.-C.; Ho Y.-L.; Liu K.-L.; Lin S.-L.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-08T02:52:22Z |
Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
|
Wu J.-H.; Chang S.-N.; Nishida T.; BO-I KUO; Lin J.-W. |
| 臺大學術典藏 |
2021-10-08T08:16:23Z |
Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer
|
MONG-WEI LIN; Su K.-Y.; Su T.-J.; Chang C.-C.; Lin J.-W.; Lee Y.-H.; Yu S.-L.; Chen J.-S.; Hsieh M.-S. |
| 臺大學術典藏 |
2021-09-04T06:18:56Z |
Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases
|
Liu C.-H.; Lin J.-W.; Tsai F.-C.; Yang P.-M.; Lai M.-Y.; Chen J.-H.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:18:54Z |
The effects of metabolic syndrome versus infectious burden on inflammation, severity of coronary atherosclerosis, and major adverse cardiovascular events
|
Dai D.-F.; Lin J.-W.; JIA-HORNG KAO; Hsu C.-N.; Chiang F.-T.; Lin J.-L.; Chou Y.-H.; Hsu K.-L.; Tseng C.-D.; Tseng Y.-Z.; Hwang J.-J. |
| 臺大學術典藏 |
2021-09-04T06:12:36Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised study
|
Liu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; JIA-HORNG KAO; Liu C.-J.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:12:35Z |
Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis
|
Liu C.-H.; Hsu S.-J.; Liang C.-C.; Tsai F.-C.; Lin J.-W.; Liu C.-J.; Yang P.-M.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:12:27Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:21Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Hsu S.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:14Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:10Z |
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients
|
Liu C.-H.; Liang C.-C.; Huang K.-W.; Liu C.-J.; Chen S.-I.; Lin J.-W.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:00Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:00Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:44Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:25Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L. |
| 臺大學術典藏 |
2021-09-04T06:11:23Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:22Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L. |
| 臺大學術典藏 |
2021-09-04T05:16:38Z |
Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals
|
Liu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-08-24T06:21:24Z |
Measurement of waist circumference: Midabdominal or iliac crest?
|
Ma W.-Y.; Yang C.-Y.; Shih S.-R.; Hsieh H.-J.; Hung C.S.; Chiu F.-C.; MAO-SHIN LIN; Liu P.-H.; Hua C.-H.; Hsein Y.-C.; Chuang L.-M.; Lin J.-W.; Wei J.-N.; Li H.-Y. |
| 臺大學術典藏 |
2021-08-24T06:21:23Z |
Measurement of visceral Fat: Should we include
|
Hung C.-S.; Lee J.-K.; Yang C.-Y.; Hsieh H.-R.; Ma W.-Y.; MAO-SHIN LIN; Liu P.-H.; Shih S.-R.; Liou J.-M.; Chuang L.-M.; Chen M.-F.; Lin J.-W.; Wei J.-N.; Li H.-Y. |
